Very concerned that this oversight currently proposed could impede patient access to existing high-quality or state-of-the-art tests and threaten needed innovation.
Patty Murray: “Very concerned that this oversight currently proposed could impede patient access to existing high-quality or…”
On the recordSeptember 19, 2016
Source
congress.govEditor's note · Context
Expressing concerns about potential negative impacts of FDA oversight on patient access to tests.
Share
More from Patty Murray
Nov 13, 2026
The Legislative Branch bill underfunds key work to support oversight of the Executive Branch, and it underfunds important efforts to keep the Capitol complex safe.
Oct 16, 2026
This policy is indefensible. The Department must immediately abandon this approach and administer appropriated funds in full alignment with both the law and the needs of the communities that rely on these programs.
Nov 19, 2026
There is no way on God’s green earth that I’m going to let Republicans jam through a funding bill that blows war spending through the roof.





